Latest News
Long COVID has always been alarming, but there’s growing concern about its possible relationship to cancer. An expert at Yale’s School of Medicine explains the factors that could cause COVID to increase someone’s cancer risk.
- June 18, 2024Source: SolveCSF.org
Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and Director of Advancement Ilise Friedman recently visited Yale School of Medicine’s Center for Infection & Immunity (CII), the Center Director, Sterling Professor Akiko Iwasaki, and her research team, as coordinated by Dr. Nicole Darricarrère, CII’s Scientific Program Director, in New Haven, CT. The Solve delegation honored Professor Iwasaki with an award to recognize her contributions to the study of infection-associated chronic conditions and illnesses, and delivered an invited talk to the Iwasaki Lab to elaborate the power of the Solve Together Real-World Platform to accelerate biomedical research for post-acute infection syndromes, such as ME/CFS and Long Covid.
- June 14, 2024
The Yale PAX LC Trial’s decentralized, participant-centric design makes it more efficient and cost-effective than standard clinical trials, its investigators say.
- May 16, 2024Source: TIME
Akiko Iwasaki, an immunobiologist at the Yale University School of Medicine, is working with Michael Tal at MIT to map an immune profile of chronic Lyme, analyzing patients’ blood and saliva samples to search for biological markers that may differentiate people who have long-term symptoms from those who don’t.
- May 15, 2024Source: Medscape
If there's one person you'd want to talk to about immunology, the immune system and COVID, holes in our knowledge base about the complex immune system, and where the field is headed, it would be Professor Iwasaki. And add to that the topic of Women in Science. Here's our wide-ranging conversation.
- May 02, 2024
In a span of three weeks, Akiko Iwasaki, PhD, was named to two prestigious Time100 lists. The first, published on April 17, named the world's 100 most influential people. The second, on May 2, specified the most influential people in health.
- April 22, 2024Source: Yale News
Yale researchers say that nasal application of neomycin shows promise in the prevention and treatment of respiratory viral infections.
- April 17, 2024Source: Yale News
Akiko Iwasaki and Priyamvada Natarajan are part of 2024’s Time 100, a list that includes leaders of government, the arts, athletics, science, and industry.
- April 17, 2024Source: TIME Magazine
Women's Health Research at Yale Investigator Akiko Iwasaki, PhD, has been named to the TIME100, TIME Magazine's annual list of the most influential people of the year from around the world.
- April 03, 2024Source: Connecticut Public Radio /WNPR
Harlan Krumholz, MD, Harold H. Hines, Jr. Professor of Medicine (Cardiology), and Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and professor of dermatology; of molecular, cellular and developmental biology; and of epidemiology (microbial diseases), discuss the association between long COVID and age, sex, race, and ethnicity.